DAX19.970 -1,4%ESt504.879 -1,6%Top 10 Crypto15,51 -4,9%Dow42.597 +0,6%Nas19.497 +0,5%Bitcoin94.850 -2,2%Euro1,0368 +0,2%Öl72,89 -0,1%Gold2.598 +0,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T NVIDIA 918422 Rheinmetall 703000 Amazon 906866 Palantir A2QA4J MicroStrategy 722713 Bayer BAY001 Micron Technology 869020 Volkswagen (VW) vz. 766403 Atos 877757 Apple 865985 Siemens Energy ENER6Y Commerzbank CBK100 Mercedes-Benz Group (ex Daimler) 710000 RWE 703712
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach Leitzins-Senkung der Fed: DAX schließt unter 20.000er Marke -- Rheinmetall erhält Milliarden-Aufträge -- Adnoc erreicht bei Covestro Squeeze-out-Grenze -- Micron, Douglas im Fokus
Top News
So reduzieren Sie Ihre Dispo-Kosten: Ratenkredite als clevere Alternative So reduzieren Sie Ihre Dispo-Kosten: Ratenkredite als clevere Alternative
NASDAQ 100 aktuell: NASDAQ 100 stärker NASDAQ 100 aktuell: NASDAQ 100 stärker
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

BioNTech (ADRs) Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
105,60 EUR -1,40 EUR -1,31 %
FSE
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.25,73 Mrd. EUR

KGV25,25Div. Rendite0,00%

WKNA2PSR2

ISINUS09075V1026

SymbolBNTX

BioNTech (ADRs) Aktien News

DatumMeistgelesen
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaCritical Insights From BioNTech Analyst Ratings: What You Need To Know
Wer­bungBioNTech (ADRs)-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaWhy Is BioNTech Stock Trading Higher On Friday?
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaThis BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaThe Analyst Landscape: 17 Takes On BioNTech
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
BenzingaBioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition
Financial TimesBioNTech strikes $950mn deal for Chinese drugmaker Biotheus
RSSBioNTech to Acquire Biotheus to Boost Oncology Strategy
GlobeNewswireBioNTech to Acquire Biotheus to Boost Oncology Strategy
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSSSC 13G/A: An amendment to the SC 13G filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaBioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
BenzingaWhat Analysts Are Saying About BioNTech Stock
BenzingaBreaking Down BioNTech: 16 Analysts Share Their Views
MotleyFoolBioNTech Se (BNTX) Q3 2024 Earnings Call Transcript
BenzingaBioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
RSSBioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
GlobeNewswireBioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSSBioNTech to Host Innovation Series R&D Day on November 14, 2024
GlobeNewswireBioNTech to Host Innovation Series R&D Day on November 14, 2024
ZacksBioNTech to Report Q3 Earnings: Is a Beat in the Cards?
GlobeNewswireBioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

BioNTech (ADRs) News

BioNTech (ADRs) News: auf dieser Seite finden Sie alle BioNTech (ADRs) News und Nachrichten zur BioNTech (ADRs) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch BioNTech (ADRs) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um BioNTech (ADRs) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.